TNF-α as an autocrine mediator and its role in the activation of Schwann cells

Neurochemical Research

Volumn 33, Issue 6, 2008, Pages 1077-1084

  Qin, Yongwei ^a,b   Cheng, Chun ^b   Wang, Haibo ^b   Shao, Xiaoyi ^b   Gao, Yongjing ^b   Shen, Aiguo ^a  

^a NANTONG UNIVERSITY   (China)

^b NANTONG MEDICAL COLLEGE   (China)

Author keywords

Apoptosis; Inflammation; Schwann cell; TNF receptor; Tumor necrosis factor

Indexed keywords

CELL SURFACE RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN S 100; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; INFLAMMATION; MEDIATOR RELEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL NERVOUS SYSTEM; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION; SCHWANN CELL;

ANIMALS; APOPTOSIS; AUTOCRINE COMMUNICATION; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SCHWANN CELLS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42149180028     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9552-1     Document Type: Article

References (24)

1. Raine CS, Bonetti B, Cannella B (1998) Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque. Rev Neurol (Paris) 154 (8-9):577-585
2. MacEwan DJ (2002) TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 14(6):477-492
3. McFarlane SM, Pashmi G, Connell MC, Littlejohn AF, Tucker SJ, Vandenabeele P, MacEwan DJ (2002) Differential activation of nuclear factor-kappaB by tumour necrosis factor receptor subtypes TNFR1 predominates whereas TNFR2 activates transcription poorly. FEBS Lett 515(1-3):119-126
4. Baud V, Karin M (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11(9):372-377
5. Hu S, Peterson PK, Chao CC (1997) Cytokine-mediated neuronal apoptosis. Neurochem Int 30(4-5):427-431
6. Bruck W, Stadelmann C (2003) Inflammation and degeneration in multiple sclerosis. Neurol Sci 24(Suppl. 5):S265-S267
7. Melton LM, Keith AB, Davis S, Oakley AE, Edwardson JA, Morris CM (2003) Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA. Glia 44(1):1-12
8. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123(Pt 11):2321-2337
9. Armati PJ, Pollard JD (1996) Immunology of the Schwann Cell. Baillieres Clin Neurol 5(1):47-64
10. Lisak P, Skundric D, Bealmear B, Ragheb S (1997) The role of cytokines in Schwann cell damage, protection, and repair. J Infect Dis 176(Suppl.2):S173- S179
11. Orlikowski D, Chazaud B, Plonquet A, Poron F, Sharshar T, Maison P, Raphael JC, Gherardi RK, Creange A (2003) Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barre syndrome and experimental autoimmune neuritis. J Neuroimmunol 134(1-2):118-127
12. Cheng C, Qin Y, Shao X, Wang H, Gao Y, Cheng M, Shen A (2007) Induction of TNF-α by LPS in Schwann cell is regulated by MAPK activation signals, Cell Mol Neurobiol doi: 10.1007/s10571-007-9215-4
13. Brockes JP, Fields KL, Raff MC (1979) Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 165(1):105-118
14. Muñoz-Fernández MA, Fresno M (1998) The role of tumour necrosis factor, interleukin6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 56(3):307-340
15. Ronet C, Darche S, Leite de Moraes M, Miyake S, Yamamura T, Louis JA, Kasper LH, Buzoni-Gatel D (2005) NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii. J Immunol 175(2):899-908
16. Murray PJ (2005) The primary mechanism of the IL-10-regulated anti-inflammatory response is to selectively inhibit transcription. Proc Natl Acad Sci USA 102(24):8686-8691
17. Ware CF, Crowe PD, Vanarsdale TL, Andrews JL, Grayson MH, Jerzy R, Smith CA, Goodwin RG (1991) Tumor necrosis factor (TNF) receptor expression in T lymphocytes: Differential regulation of the type 1 TNF receptor during activation of resting and effector T cells. J Immunol 147(12):4229-4238
18. Vilcek J, Lee TH (1991) Tumor necrosis factor: new insights into the molecular mechanisms of its multiple actions. J Biol Chem 266(12):7313-7316
19. Rothe M, Wong SC, Henzel WJ, Goeddel DV (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78(4):681-692
20. Hsu H, Shu HB, Pan MG, Goeddel DV (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84(2):299-308
21. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA Jr, Goeddel DV (1991) The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88(20):9292-9296
22. Pan W, Zadina JE, Harlan RE, Weber JT, Banks WA, Kastin AJ (1997) Tumor necrosis factor-alpha: a neuromodulator in the CNS. Neurosci Biobehav Rev 21(5):603-613
23. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE (1993) Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151(4):2132-2141
24. Nishie M, Mori F, Ogawa M, Sannohe S, Tanno K, Kurahashi K, Kuroda N, Wakabayashi K (2004) Multinucleated astrocytes in old demyelinated plaques in a patient with multiple sclerosis. Neuropathology 24(3):248-253